Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
Immunotherapeutic Agents in ongoing clinical trials.
| Molecule | Clinical Trial | Phase |
|---|---|---|
| Ipilimumab/Nivolumab | NCT02880020 | II |
| Ipilimumab | NCT01738139 | I |
| Ipilimumab/Nivolumab | NCT02500797 | II |
| Ipilimumab/Nivolumab | NCT02834013 | II |
| Ipilimumab/Nivolumab | NCT02982486 | II |
| Spartalizumab | NCT04000529 | I |
| PDR001 | NCT03609424 | I/II |
| Avelumab + Regorafenib | NCT03475953 | I/II |
| Avelumab + Axitinib | NCT04258956 | II |
| Pembrolizumab + Epacadostat | NCT03291054 | II |
| NCT02406781 | II |
